Publications
- Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate((R)): Final report from a prospective study2018 | Second Faculty of Medicine
- Successful prophylactic treatment of FEIBA in the prevention of bleeding in patients with severe haemophilia A and high titre of FVIII inhibitor2017 | Second Faculty of Medicine
- Novel approaches to the treatment of hemophilia2016 | Second Faculty of Medicine
- Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children: Results of a phase 3 trial2016 | Second Faculty of Medicine
- Inhibitors incidence rate in Czech previously untreated patients with haemophilia A has not increased since introduction of recombinant factor VIII treatment in 20032015 | Second Faculty of Medicine
- Inhibitor development in non-severe haemophilia across Europe2015 | Second Faculty of Medicine
- Introduction of the treatment with recombinant FVIII has not increased the inhibitor incidence rate in Czech PUPs with haemophilia A2014 | Second Faculty of Medicine
- Response to the Letter to the Editor by Ewenstein BM and Reininger AJ2013 | Second Faculty of Medicine
- A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management2012 | Second Faculty of Medicine
- Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate (R): interim report from an ongoing prospective clinical study2011 | Second Faculty of Medicine
Loading network view...